ISRCTN68736636已完成不适用
The European study of the effectiveness of haloperidol, amisulpride, olanzapine, quetiapine, and ziprasidone on loss of retention in first episode schizophrenia
European Group for Research in Schizophrenia (EGRIS) (Austria)0 个研究点目标入组 500 人开始时间: 2005年5月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
- •2. Age 18 - 40 years
- •We will include an unselected group of 500 patients in 13 European countries (Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Italy, The Netherlands, Poland, Romania, Spain, Sweden, and Switzerland) and Israel, with a total of 49 participating sites.
排除标准
- •1. A time interval between the onset of positive symptoms (hallucinations and/or delusions) and study entry exceeding two years
- •2. Prior use of anti-psychotic medication longer than an episode of two weeks in the previous year and/or six weeks lifetime
- •3. Intolerance to one of the drugs in this study
- •4. The presence of one or more of the contra-indications against any of the study drugs
研究者
相似试验
招募中
3 期
Comparison of the effect of haloperidol and quetiapine in the prevention of delirium in patients with end-stage cancer candidates receiving palliative care at homeDelirium.Delirium due to known physiological conditionIRCT20201205049612N1Esfahan University of Medical Sciences60
招募中
3 期
Evaluation of the Effect of Haloperidol, Risperidone, and Quetiapine in the Delirium of Cancer PatientsCondition 1: Delirium. Condition 2: Malignancy.Delirium due to known physiological conditionMalignant (primary) neoplasm, unspecifiedC80.1IRCT20190404043159N3Esfahan University of Medical Sciences60
已完成
2 期
Haploidentical hematopoietic stem cell transplantation for the treatment of severe aplastic anemia patients.IRCT20140818018842N29Tehran University of Medical Sciences10
已完成
不适用
A Pilot Study to Evaluate Safety and Efficacy of HLA-mismatched Granulocyte Transfusions in the Treatment of Patients with Solid Malignant Tumors Who Are Resistant to Standard Cancer Therapy or for Whom No Standard Cancer Therapy ExistsCTRI/2012/11/003116Munogenics Inc USA22
已完成
不适用
Home based cardiac rehabilitatioCoronary heart disease.Acute myocardial infarctionIRCT2016022926820N1ational Institute for Medical Research Development (NIMAD)240